Previous close | 4.5700 |
Open | 4.6100 |
Bid | 4.4500 x 900 |
Ask | 4.4900 x 1800 |
Day's range | 4.4100 - 4.6800 |
52-week range | 4.0300 - 8.9600 |
Volume | |
Avg. volume | 3,269,659 |
Market cap | 924.363M |
Beta (5Y monthly) | 1.93 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Heron Therapeutics (HRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive to...